FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

Health & LifestyleNews
840

Listen to article (english)

Translate to Spanish or other 102 languages!

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-daily-pill-treat-low-libido-women-postmenopause-explainer?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-12-19&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Heart Association Highlights 2025’s Major Research Findings
Next article
From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

More Articles

STHS Urges RGV Residents to Take Action Against Flu

With flu activity on the rise, now is the time to take steps to protect yourself and those you love.

Reversing Radiation-Activated Immune Suppression in Cancer

Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

STHS and Prominence Health Help Valley Seniors Outsmart Stroke

A stroke can strike without warning, leaving little time to react. Knowing the symptoms and seeking immediate medical care can significantly improve a person's chances of survival and long-term recovery.

$87 Million Poured Into Rural Healthcare Through New Grants

Governor Greg Abbott announced that the Texas Health and Human Services Commission (HHSC) plans to award $87 million in Rural Texas Strong grants to 129 rural healthcare providers throughout the state.
- Advertisement -